Where can I find ALMR's financial statements?

Alamar Biosciences, Inc. (ALMR)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for ALMR?

Alamar Biosciences, Inc. (ALMR) statements are available back to its earliest filed 10-K, typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does ALMR update its statements?

Alamar Biosciences, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

ALMR (Alamar Biosciences, Inc.) is a recent IPO.

It began trading on April 17, 2026, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates. The affected sections are flagged individually so you can tell limited history from missing data.

ALMR

Alamar Biosciences, Inc.

NASDAQ·Biotechnology · Healthcare

$30.69$0.97+3.26%

After hours·$30.63−0.20%

Market cap$2.13B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About ALMR

Where can I find ALMR's financial statements?: Alamar Biosciences, Inc. (ALMR)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for ALMR?: Alamar Biosciences, Inc. (ALMR) statements are available back to its earliest filed 10-K, typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does ALMR update its statements?: Alamar Biosciences, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

ALMR (Alamar Biosciences, Inc.) is a recent IPO.

ALMR

Alamar Biosciences, Inc.

NASDAQ·Biotechnology · Healthcare

$30.69$0.97+3.26%

After hours·$30.63−0.20%

Market cap$2.13B·Market closed·Oct 23 4:00 PM EDT

USD · values shown as reported

Line item	FY 2025	Trend
Revenue	$74.21M	—
Cost of revenue	$32.51M	—
Gross profit	$41.71M	—
Research & development	$37.47M	—
SG&A (combined)	$35.57M	—
Total operating expenses	$73.04M	—
Operating income	−$31.33M	—
Interest income	$2.16M	—
Interest expense	$401.00K	—
Other income / (expense), net	$2.18M	—
Income before tax	−$29.15M	—
Income tax expense	$665.00K	—
Net income	−$29.82M	—

EPS (basic)	−$0.45	—
EPS (diluted)	−$0.45	—
Weighted avg shares (basic)	66,521,424	—
Weighted avg shares (diluted)	66,521,424	—

Depreciation & amortization	$3.86M	—
EBITDA	−$24.89M	—

Frequently Asked Questions About ALMR

Where can I find ALMR's financial statements?: Alamar Biosciences, Inc. (ALMR)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for ALMR?: Alamar Biosciences, Inc. (ALMR) statements are available back to its earliest filed 10-K, typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does ALMR update its statements?: Alamar Biosciences, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.